MCP Server For Financial Data by EODHD Learn more

Try our APIs with free plan!

Aspire BioPharma, Inc. Financial Data Overview

Price chart is built with Anychart

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.

Prev. Close 7.7598
Open 7.6473
High 7.9887
Low 7.5262
52 wk Range 3.309-1050.36
Market Cap 10 012 K
Shares Outstanding 1 295 K
Revenue 34 555
Beta 0.111

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Aspire BioPharma, Inc. (top by weight)

Ticker
100-day Price Change
Weight
VXF.US Vanguard Extended Market Index Fund ETF Shares
20.72 (9.14%)
0.00

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Aspire BioPharma, Inc. data using free add-ons & libraries


Get Aspire BioPharma, Inc. Fundamental Data

Aspire BioPharma, Inc. Fundamental data includes:

  • Net Revenue: 34 555
  • EBITDA:
  • Earnings Per Share: -7
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Aspire BioPharma, Inc. Earnings data

Corporate Events Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2026-08-12
  • EPS/Forecast: NaN
GET THE PACKAGE

Get Aspire BioPharma, Inc. End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Aspire BioPharma, Inc. News

Get Aspire BioPharma, Inc. fresh news feed via Financial News API

Corporate Events Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Live chat support

Send the request

Leave your email and our team will contact you ASAP.